Ocuphire Pharma Inc (OCUP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | OCUP | BMY | AMGN | GILD | REGN |
| Company | Ocuphire Pharma Inc | Bristol-Myers Squibb Company | Amgen Inc | Gilead Sciences Inc | Regeneron Pharmaceuticals |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NASDAQ | NASDAQ | NASDAQ |
| Open | 1.5200 | 49.00 | 270.63 | 66.58 | 906.90 |
| High | 1.5623 | 49.00 | 272.39 | 66.72 | 912.86 |
| Low | 1.5200 | 48.56 | 269.66 | 66.41 | 905.00 |
| Last | 1.5450 | 48.75 | 273.10 | 66.69 | 915.28 |
| Change | +0.0050 | -0.24 | -0.44 | -0.34 | +7.96 |
| % Change | +0.32% | -0.49% | -0.16% | -0.51% | +0.88% |
| Volume | 8,412 | 665,765 | 138,225 | 550,794 | 33,873 |
| 20-Day Average Volume | 276,006 | 10,489,543 | 2,056,261 | 6,094,725 | 424,829 |
| Previous Close | 1.5400 | 48.99 | 273.54 | 67.03 | 907.32 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 1.8253 | 50.35 | 271.52 | 69.05 | 926.57 |
| 20-Day Raw Stochastic | 4.85% | 14.72% | 41.98% | 8.85% | 25.25% |
| 20-Day Relative Strength | 31.65% | 40.17% | 47.60% | 31.62% | 41.91% |
| Weighted Alpha | -69.97 | -26.51 | +10.80 | -21.55 | +14.85 |
| Today's Opinion | 100% Sell | 88% Sell | 56% Sell | 100% Sell | 24% Buy |
| Previous Opinion | 100% Sell | 88% Sell | 40% Sell | 100% Sell | 24% Buy |
| Last Month's Opinion | 100% Sell | 8% Sell | 24% Buy | 88% Sell | 80% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -11.45% since 04/17/24 | +1.64% since 04/17/24 | +3.15% since 04/17/24 | -0.49% since 04/17/24 | +1.23% since 04/17/24 |
| Low | 1.5000 on 04/22/24 | 47.62 on 04/18/24 | 260.68 on 04/19/24 | 65.90 on 04/18/24 | 891.46 on 04/19/24 |
| High | 1.7800 on 04/18/24 | 49.56 on 04/22/24 | 274.48 on 04/23/24 | 67.68 on 04/23/24 | 920.73 on 04/19/24 |
| 1-Month | |||||
| %Chg | -24.10% since 03/22/24 | -6.36% since 03/22/24 | -1.37% since 03/22/24 | -8.27% since 03/22/24 | -5.69% since 03/22/24 |
| Low | 1.5000 on 04/22/24 | 47.62 on 04/18/24 | 260.68 on 04/19/24 | 65.90 on 04/18/24 | 890.43 on 04/16/24 |
| High | 2.3400 on 04/02/24 | 54.47 on 03/28/24 | 288.57 on 03/28/24 | 73.87 on 03/28/24 | 976.75 on 03/27/24 |
| 3-Month | |||||
| %Chg | -42.94% since 01/24/24 | -3.21% since 01/24/24 | -10.84% since 01/24/24 | -16.25% since 01/24/24 | -3.80% since 01/24/24 |
| Low | 1.5000 on 04/22/24 | 47.58 on 02/06/24 | 260.68 on 04/19/24 | 65.90 on 04/18/24 | 890.43 on 04/16/24 |
| High | 2.8500 on 01/30/24 | 55.03 on 03/13/24 | 329.72 on 02/05/24 | 81.06 on 01/25/24 | 998.33 on 02/28/24 |
| 6-Month | |||||
| %Chg | -47.77% since 10/24/23 | -13.36% since 10/24/23 | -1.35% since 10/24/23 | -14.77% since 10/24/23 | +13.42% since 10/24/23 |
| Low | 1.5000 on 04/22/24 | 47.58 on 02/06/24 | 249.70 on 10/31/23 | 65.90 on 04/18/24 | 769.19 on 10/27/23 |
| High | 3.3994 on 01/10/24 | 56.77 on 10/25/23 | 329.72 on 02/05/24 | 87.86 on 01/19/24 | 998.33 on 02/28/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 38,212 | 99,290,928 | 146,720,288 | 83,457,512 | 99,589,264 |
| Shares Outstanding, K | 24,813 | 2,026,759 | 536,376 | 1,245,077 | 109,762 |
| Annual Sales | 19,050,000 | 45,006,000,000 | 28,190,000,000 | 27,116,000,000 | 13,117,200,000 |
| Annual Net Income | -9,990,000 | 8,025,000,000 | 6,717,000,000 | 5,665,000,000 | 3,953,600,000 |
| Last Quarter Sales | 1,690,000 | 11,477,000,000 | 8,196,000,000 | 7,114,000,000 | 3,434,300,000 |
| Last Quarter Net Income | -4,800,000 | 1,762,000,000 | 767,000,000 | 1,429,000,000 | 1,159,600,000 |
| 60-Month Beta | 0.33 | 0.39 | 0.58 | 0.19 | 0.11 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.21 on 03/08/24 | 1.70 on 02/02/24 | 4.71 on 02/06/24 | 1.72 on 02/06/24 | 11.86 on 02/02/24 |
| Latest Earnings Date | 05/20/24 | 04/25/24 | 05/02/24 | 04/25/24 | 05/02/24 |
| Most Recent Dividend | N/A | 0.600 on 04/04/24 | 2.250 on 02/15/24 | 0.770 on 03/14/24 | N/A |
| Next Ex-Dividends Date | N/A | 04/04/24 | 05/16/24 | 03/14/24 | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 6.55 | 14.58 | 9.96 | 23.95 |